Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus

Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus

Abstract Early reports indicate that metformin, a clinical drug administered to treat type 2 diabetes mellitus (T2DM), was found to be associated with a better prognosis of cancer. The objective of this study was retrospectively analyzed the effect of metformin on the outcomes of Chinese breast canc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tianli Hui, Chao Shang, Liu Yang, Meiqi Wang, Ruoyang Li, Zhenchuan Song
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/9acc9659bf2f495683f2261e7cfaff34
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares